Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives

Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives

US Patent 9717743 · Granted Aug 1, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biodegradable intravitreal tyrosine kinase implants2021
4-pregenen-11β-17-21-triol-3,20-dione derivatives2019
4-pregenen-11β-17-21-triol-3,20-dione derivatives2019
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2019
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,22019
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,22019
Biodegradable intravitreal tyrosine kinase implants2018
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2017
4-pregenen-11β-17-21-triol-3,20-dione derivatives2016
4-pregenen-11β-17-21-triol-3,20-dione derivatives2016
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2016
Biodegradable intravitreal tyrosine kinase implants2016